Literature DB >> 10369131

Secretion of stem cell factor by alveolar fibroblasts in interstitial lung diseases.

E Fireman1, S Kivity, I Shahar, T Reshef, Y A Mekori.   

Abstract

Sarcoidosis (SA) and diffuse interstitial fibrosis (DIF) are characterized by alveolitis, mast cell hyperplasia and increased fibroblast proliferation. Stem cell factor (SCF) stimulates proliferation of hematopoietic progenitor cells involved in mast and stromal cell interaction. We assessed the role of SCF secreted by alveolar fibroblasts (AFb) in the development of fibrosis of DIF and SA in six patients with SA and six patients with DIF. Bronchoalveolar lavage (BAL) was performed by conventional methods. A total of 500 cells were differentially counted from Giemsa-stained cytopreps. AFb and supernatants were recovered from long-term cultures of BAL cells and from 24 h cultures of confluent AFb. Levels of SCF were measured by ELISA. Alpha actin content of AFb was characterized by immunohistochemistry. The expression of AFb mRNA for IL1-alpha and beta, TGF-beta, IFN-gamma, IL-2, IL-4, IL-5 and IL-6 was determined by RT-PCR. There was a lymphocytic predominance in the SA patients and an increase in neutrophils and eosinophils in DIF. SCF secreted by AFb from DIF was significantly higher than in SA. TNF + IL-1 significantly decreased the secretion of SCF by AFb. There was a positive correlation between SCF levels and the percentage eosinophils but not for metachromatic cells. Alpha-actin expression of AFb in DIF was significantly higher than in SA. Cytokine mRNA was extracted from AFb of two SA and two DIF patients. The profile showed that only in stimulated AFb isolated from the DIF patients can IL-5 transcripts be visualized. In conclusion, AFb can contribute to the onset of fibrosis by secreting SCF and IL-5 which, in turn, may recruit eosinophils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369131     DOI: 10.1016/s0165-2478(99)00020-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

Review 1.  Mast cells in airway diseases and interstitial lung disease.

Authors:  Glenn Cruse; Peter Bradding
Journal:  Eur J Pharmacol       Date:  2015-05-08       Impact factor: 4.432

2.  Engraftment of neonatal lung fibroblasts into the normal and elastase-injured lung.

Authors:  Ping-Ping Kuang; Edgar Lucey; David C Rishikof; Donald E Humphries; Daniel Bronsnick; Ronald H Goldstein
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-21       Impact factor: 6.914

3.  Tissue distribution of stem cell factor in adults.

Authors:  Brittni M Foster; Kendall L Langsten; Ammar Mansour; Lihong Shi; Bethany A Kerr
Journal:  Exp Mol Pathol       Date:  2021-08-24       Impact factor: 4.401

4.  Eosinophil activation of fibroblasts from chronic allergen-induced disease utilizes stem cell factor for phenotypic changes.

Authors:  Vladislav Dolgachev; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

5.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

6.  Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.

Authors:  Lin Ding; Vladilsav Dolgachev; Zhuang Wu; Tianju Liu; Taku Nakashima; Zhe Wu; Matthew Ullenbruch; Nicholas W Lukacs; Zidi Chen; Sem H Phan
Journal:  J Pathol       Date:  2013-04-03       Impact factor: 7.996

7.  Effect of montelukast, a cysteinyl receptor antagonist, on myofibroblasts in interstitial lung disease.

Authors:  Elizabeth Fireman; Yehuda Schwartz; Abraham Mann; Joel Greif
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

8.  Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study.

Authors:  Sebastian Majewski; Xingwu Zhou; Joanna Miłkowska-Dymanowska; Adam J Białas; Wojciech J Piotrowski; Andrei Malinovschi
Journal:  ERJ Open Res       Date:  2021-03-29

Review 9.  Are mast cells instrumental for fibrotic diseases?

Authors:  Catherine Overed-Sayer; Laura Rapley; Tomas Mustelin; Deborah L Clarke
Journal:  Front Pharmacol       Date:  2014-01-21       Impact factor: 5.810

Review 10.  The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung.

Authors:  Laura Florez-Sampedro; Shanshan Song; Barbro N Melgert
Journal:  Regeneration (Oxf)       Date:  2018-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.